Stock Market Stories and Insights

<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;;'>AP</div>
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
While some baby boomers are getting worried about healthcare space, we are going to digest both, Ampio Pharmaceuticals and Precision BioSciences as potential shorter-term investments. We are going to discuss some of the competitive aspects of both Ampio and Precision.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;;'>OP</div>
  over three weeks ago at Macroaxis 
By Achuva Shats
This short post will outline OptiNose as a possible investment alternative for your portfolios. We will provide a perspective on OptiNose future direction.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;;'>GEV</div>
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
The next fiscal quarter end is expected on the 31st of December 2020. The stock is still going through an active upward rally. While some baby boomers are getting worried about their positions in basic materials space, it is entirely reasonable to outline Gevo as a possible position for your existing portfolio. We will evaluate why we are still optimistic in anticipation of a recovery.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;;'>GT</div>
  over two weeks ago at Macroaxis 
By Ellen Johnson
The stock continues to experience an active upward rally. As many investors are getting excited about consumer cyclical space, it is fair to summarize Good Times Restaurants as an investment option. We will analyze why Good Times investors may still consider a stake in the business. Here we also measure the ability of Good Times to meet its long-term debt obligations, such as interest payments on debt, the final principal payment on the debt, and any other fixed obligations like lease payments.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#4E8BFC;color: #ffffff;font-size:1.1em;;'>OS</div>
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
Today's short post will sum up One Stop as your potential position. We will discuss the question of why retail investors should continue to be confident in One Stop outlook.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;;'>AP</div>
  over three weeks ago at Macroaxis 
By Raphi Shpitalnik
The next fiscal quarter end is expected on the 31st of December 2020. The stock experiences an active upward rally. Because some millenniums are getting more into healthcare space, we are going to digest the feasibility of inclusion Ampio into your portfolio. I will address why shareholders ignored this entity since the beginning of the latest economic outlook.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;;'>EE</div>
  over three weeks ago at Macroaxis 
By Raphi Shpitalnik
It looks as if Eos Energy will continue to recover much faster as its share price surged up 44.56% today. Eos Energy's current daily volatility is 8.94 percent, with a beta of 0.21 and an alpha of 1.45 over DOW. While some millenniums are indifferent towards favorable retirement market, it makes sense to digest Eos Energy Enterprises. I will address the reasons why this entity does not get much respect from shareholders under the current market uncertainty.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;;'>GEV</div>
  over three weeks ago at Macroaxis 
By Achuva Shats
While some millenniums are indifferent towards basic materials space, it makes sense to outline Gevo Inc. Why are we still confident in anticipation of a complete recovery. Is current Gevo Inc value sustainable? We will go over the entity valuation drivers to give you a better outlook on taking a position in it.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;;'>AP</div>
  over three weeks ago at Macroaxis 
By Raphi Shpitalnik
Ampio Pharmaceuticals is currently generating 1.6876% in daily expected returns and assumes 9.2801% risk (volatility on return distribution) over the 60 days horizon. As many investors are getting excited about healthcare space, it is fair to digest Ampio Pharmaceuticals. We are going to discuss if the current expected returns justify Ampio Pharmaceuticals' volatility. The latest Ampio risk factors may impact the value of the stock as we estimate Ampio Pharmaceuticals as currently undervalued. The real value is approaching 2.47 per share.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;;'>HC</div>
  over three weeks ago at Macroaxis 
By Raphi Shpitalnik
Harvest Capital is currently generating 1.0185% in daily expected returns and assumes 5.8786% risk (volatility on return distribution) over the 60 days horizon. While some risk-loving traders are indifferent towards current market volatility, it is reasonable to recap the risk of investing in Harvest Capital Credit. We are going to focus on if the current expected returns justify Harvest Capital's volatility.